-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Bicycle Therapeutics plc (NASDAQ:BCYC) Given Average Rating of “Moderate Buy” by Brokerages
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eight research firms that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price objective […]
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eight research firms that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price objective […]
